# A study on the temporal patterns, anatomical distribution, and influencing factors of radiation therapy-associated second primary cancers in gynecological malignancies

## TL;DR

This study examines secondary cancers that develop after radiation therapy for gynecological cancers, focusing on their timing, location, and risk factors.

## Contribution

The study identifies clinical patterns and risk factors for radiation-induced secondary cancers in gynecological malignancies.

## Key findings

- Most secondary cancers occurred outside the original radiation field and within 5–10 years post-treatment.
- Cervical cancer survivors had longer intervals to secondary cancer onset compared to endometrial cancer survivors.
- Treatment history, including surgery and chemotherapy, influenced the timing and site of secondary cancers.

## Abstract

To systematically analyze the clinical characteristics of post-radiotherapy secondary primary cancers (SPC) after treatment for gynecological malignancies, with the aim of informing and optimizing tumor management strategies.

A retrospective collection of clinical data for 36 patients with gynecological malignancies who underwent radiotherapy at our hospital from January 2004 to December 2021.

The first primary cancer was predominantly cervical cancer (31 cases, 86.1%), with endometrial cancer accounting for 5 cases. Radiotherapy-related variables included the median radiotherapy duration of 42.5 days, external irradiation dose of 49.375 Gy, and total dose of 69.5 Gy; FIGO stages I/II/III were 7/18/11; lymph node metastasis in 6 cases; HPV positive in 20 cases; surgical history in 18 cases and chemotherapy history in 30 cases. The SPC cohort had a median onset age of 58 years and a median interval of 8 years after radiotherapy, with primary sites mostly in the rectum/colon and uterus; 24 cases occurred outside the radiotherapy field. Surgical, radiotherapy, and chemotherapy histories all influenced the timing and site of SPC. The median onset age after radiotherapy and interval to SPC were significantly longer in the cervical cancer group than in the endometrial cancer group (P = 0.01), and most SPC occurred within 5–10 years.

The pathological features and treatment history of the initial cancer were associated with the timing and location of SPC. Analyses of post-radiotherapy SPC characteristics provide a scientific basis for optimizing clinical management and reducing SPC risk.